Trial NCT03712605

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2018-02217
Secondary IDs: EA6174 NCI-2018-02217 U10CA180820

Last trial update was posted on 2024-04-08

MeSH Interventions

Pembrolizumab

MeSH Conditions

Carcinoma Carcinoma, Merkel Cell

Other Conditions

Pathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8 Pathologic Stage II Cutaneous Merkel Cell Carcinoma AJCC v8 Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8

Stopping Reasons

Other - Reached planned accrual; increase being considered

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID